Geoffrey Beran Rose - 01 Jun 2021 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
Chief Commercial Officer
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Geoffrey Beran Rose
Issuer symbol
LUNG
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 20:22:44 UTC
Previous filing
25 May 2021
Next filing
19 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Award $0 +17,600 +11% $0.000000 180,885 01 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Employee Stock Option (right to buy) Award $0 +39,900 $0.000000 39,900 01 Jun 2021 Common Stock 39,900 $43.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021.
F2 The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021.